Related Experiment Video
Updated: Aug 9, 2026

Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Published on: June 8, 2018
BRCA1 participates in DNA decatenation
Zhenkun Lou1, Katherine Minter-Dykhouse, Junjie Chen
1Department of Oncology, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA.
Abstract:
The tumor suppressor BRCA1 has an important function in the maintenance of genomic stability. Increasing evidence suggests that BRCA1 regulates cell cycle checkpoints and DNA repair after DNA damage. However, little is known about its normal function in the absence of DNA damage. Here we show that BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells. Similar to cells treated with the topoisomerase IIalpha inhibitor ICRF-193, BRCA1-deficient cells show lagging chromosomes, indicating a defect in DNA decatenation and chromosome segregation. More directly, BRCA1 deficiency results in defective DNA decatenation in vitro. Finally, topoisomerase IIalpha is ubiquitinated in a BRCA1-dependent manner, and topoisomerase IIalpha ubiquitination correlates with higher DNA decatenation activity. Together these results suggest an important role of BRCA1 in DNA decatenation and reveal a previously unknown function of BRCA1 in the maintenance of genomic stability.
Insights
The tumor suppressor BRCA1 is crucial for genomic stability. This study reveals BRCA1
Area of Science:
- Cell Biology
- Genetics
- Molecular Biology
Background:
- The BRCA1 tumor suppressor is known for its role in genomic stability, particularly in DNA repair and cell cycle checkpoints after DNA damage.
- Its function in normal cells, without DNA damage, remains less understood.
Purpose of the Study:
- To investigate the normal function of BRCA1 in maintaining genomic stability, specifically its role in DNA decatenation and chromosome segregation.
- To explore the relationship between BRCA1 and topoisomerase IIalpha.
Main Methods:
- Immunofluorescence microscopy to observe BRCA1 and topoisomerase IIalpha colocalization in S phase cells.
- Analysis of chromosome segregation in BRCA1-deficient cells and cells treated with a topoisomerase IIalpha inhibitor (ICRF-193).
- In vitro DNA decatenation assays using extracts from BRCA1-deficient cells.
- Western blotting to assess topoisomerase IIalpha ubiquitination.
Main Results:
- BRCA1 interacts and colocalizes with topoisomerase IIalpha in S phase cells.
- BRCA1-deficient cells exhibit chromosome lagging, indicative of defective DNA decatenation and segregation, similar to cells treated with ICRF-193.
- BRCA1 deficiency impairs DNA decatenation activity in vitro.
- Topoisomerase IIalpha ubiquitination is dependent on BRCA1 and correlates with increased DNA decatenation activity.
Conclusions:
- BRCA1 plays a significant role in DNA decatenation, a process essential for chromosome segregation.
- This study uncovers a novel function of BRCA1 in maintaining genomic stability through its regulation of topoisomerase IIalpha activity.
Related Concept Videos
Base Excision Repair
The first step of...
DNA Damage can Stall the Cell Cycle
Homologous Recombination
Restarting Stalled Replication Forks
Base Excision Repair
The first step of...
Homologous Recombination

